Tuesday, 26 September 2017

Axovant's Alzheimer's drug fails late-stage trial

(Reuters) - Axovant Sciences Ltd said on Tuesday its experimental drug targeting Alzheimer's patients failed to meet the main goals in a late-stage trial.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)